The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Cilag GmbH International, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced its decision to discontinue the collaboration ...
read more
Novartis announced Phase II primary endpoint data showing investigational iptacopan (LNP023) – a first-in-class, oral, targeted factor B inhibitor – ...
read more
Spinogenix, Inc. a pharmaceutical company focused on the development of novel synaptogenic small molecule therapies for CNS disorders and rare ...
read more
Ortho Regenerative Technologies Inc, a clinical stage orthobiologics company focused on the development of novel soft tissue repair regenerative ...
read more
Novartis announced results from the pivotal Phase III RATIONALE 302 trial showing the investigational anti-PD-1 immune checkpoint inhibitor ...
read more
Aeterna Zentaris Inc., a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic ...
read more
The FDA is finalizing two guidance documents and making available two draft guidance documents to help ensure that prescription drugs are identified ...
read more
Merck announced that it has completed the spinoff of Organon & Co. (Organon). “Today marks a significant milestone for both Merck and Organon. Organon...
read more
Organon celebrates its launch as a global women’s health company with employees and women from around the world, as the Organon executive leadership ...
read more
The FDA granted accelerated approval to infigratinib, a kinase inhibitor for adults with previously treated, unresectable locally advanced or ...
read more
Ipsen announced that its New Drug Application (NDA) for palovarotene, an oral, investigational, selective RAR? agonist for the prevention of ...
read more
VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed ...
read more
A new post-hoc analysis of pooled data from the TULIP Phase III clinical trials being presented at the annual European Congress of Rheumatology (EULAR...
read more
Bristol Myers Squibb announced that the European Commission (EC) has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment...
read more
MorphoSys and Constellation Pharmaceuticals announced that they have entered into a definitive agreement whereby MorphoSys will acquire Constellation ...
read more